Sosei to acquire Japanese drug delivery venture
This article was originally published in Scrip
Executive Summary
Sosei is to acquire Activus Pharma, a small Japanese venture specialising in nanoparticle-based drug formulations, for a cash consideration of around ¥500 million ($5.5 million).